OMT-111 for Terminal Stage Solid Tumors
Clinical trial NCT04520386 · UNKNOWN
Trial details
- NCT number
- NCT04520386
- Sponsor
- MetiMedi Pharmaceuticals
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-10-01
- Primary completion
- 2022-06-30
- Enrollment
- 78
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.